MedPath

Corline Biomedical AB

Corline Biomedical AB logo
🇸🇪Sweden
Ownership
Public
Established
1991-01-01
Employees
1
Market Cap
-
Website
http://www.corline.com

Renaparin® in Kidney Transplantation

Phase 1
Completed
Conditions
Delayed Graft Function
Interventions
Drug: Placebo
First Posted Date
2018-12-12
Last Posted Date
2020-07-01
Lead Sponsor
Corline Biomedical AB
Target Recruit Count
16
Registration Number
NCT03773211
Locations
🇸🇪

Transplantationscentrum, Sahlgrenska University Hospital, Gothenburg, Sweden

🇸🇪

Department of Transplantation Surgery, Karolinska University Hospital, Huddinge, Stockholm, Sweden

🇸🇪

Department of Surgical Sciences, Section of Transplantation Surgery, Uppsala University Hospital, Uppsala, Sweden

Heparinized Islets in Clinical Islet Transplantation

Not Applicable
Conditions
Type 1 Diabetes Mellitus
Interventions
Procedure: Transplantation of islets with heparin coating
First Posted Date
2008-05-16
Last Posted Date
2018-12-10
Lead Sponsor
Corline Biomedical AB
Target Recruit Count
10
Registration Number
NCT00678990
Locations
🇸🇪

Department of Transplantation Surgery, Karolinska University Hospital, Stockholm, Sweden

🇸🇪

Department of Transplantation and Liver Surgery, Uppsala University Hospital, Uppsala, Sweden

© Copyright 2025. All Rights Reserved by MedPath